Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Castle Biosciences, Inc. - Common stock (NQ:CSTL)

23.56 -1.00 (-4.07%)
Streaming Delayed Price Updated: 1:16 PM EDT, Jul 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Castle Biosciences, Inc. - Common stock

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
News headline image
Castle (CSTL) Q1 2026 Earnings Transcript ↗
Castle (CSTL) Q1 2026 Earnings Transcript 
Via The Motley Fool
Castle Biosciences Inc (NASDAQ:CSTL) Beats Q1 Estimates, Raises Full-Year Guidance ↗
Via Chartmill
News headline image
Prospective, Multi-center Study Published in Future Oncology Demonstrates DecisionDx®-Melanoma’s i31-SLNB Result Outperforms Staging Criteria in Identifying Patients with Cutaneous Melanoma Below the 5% NCCN Threshold for Forgoing SLNB
From Castle Biosciences, Inc.
Via GlobeNewswire
News headline image
DecisionDx®-Melanoma’s i31-SLNB: Report from the Largest Prospective Multicenter Study to Date Confirms 2.6% Nodal Positivity in Patients Predicted to Have Less Than 5% Risk
From Castle Biosciences, Inc.
Via GlobeNewswire
Castle Biosciences Inc (NASDAQ:CSTL) Reports Q4 2025 Revenue Beat Amid Profitability Transition ↗
Via Chartmill
News headline image
This $56 Million Sale Slashed One Fund's DigitalBridge Stake Amid 49% Stock Surge ↗
DigitalBridge Group operates at the forefront of digital infrastructure, managing assets critical to global connectivity and data growth. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
This Fund Just Disclosed a $29 Million Sale of a Beauty Stock Up 20% This Past Year ↗
e.l.f. Beauty delivers cosmetics and skin care through a multi-channel model, with recent filings highlighting strong revenue growth. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
What's Behind This $32 Million Bet on Baidu Amid a 36% Stock Rally? ↗
Baidu delivers online marketing, cloud, and AI-powered services to businesses and consumers across China’s digital economy. 
Via The Motley Fool
Topics Artificial Intelligence Economy Regulatory Compliance
News headline image
Castle Biosciences to Present Data at SSO 2026 on DecisionDx®-Melanoma’s i31-SLNB, Identifying T1b–T2a Melanoma Patients Who May Safely Avoid SLNB
From Castle Biosciences, Inc.
Via GlobeNewswire
News headline image
Castle Biosciences Announces Grand Opening of New Corporate Headquarters in Friendswood, Texas
From Castle Biosciences, Inc.
Via GlobeNewswire
News headline image
Castle Biosciences (CSTL) Earnings Transcript ↗
Castle Biosciences (CSTL) Earnings Transcript 
Via The Motley Fool
News headline image
Castle Biosciences Reports Fourth Quarter and Full–Year 2025 Results
From Castle Biosciences, Inc.
Via GlobeNewswire
News headline image
Prospective Validation Study in JAAD Demonstrates Castle Biosciences’ AdvanceAD-Tx™ Test Identifies Patients More Likely to Achieve Faster and Deeper Responses with JAK Inhibitor Therapy in Moderate-to-Severe Atopic Dermatitis
Study data show that AdvanceAD-Tx can stratify patients by molecular profile identifying those more likely to achieve near-clear skin (EASI-90), faster time to response and meaningful patient-reported... 
From Castle Biosciences, Inc.
Via GlobeNewswire
News headline image
Castle Biosciences to Release Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call on Thursday, Feb. 26, 2026
From Castle Biosciences, Inc.
Via GlobeNewswire
News headline image
AIGH Capital Dumps 2.6 Million Lumen Technologies Shares In $15.6 Million Exit ↗
This telecom provider delivers fiber, cloud, and security services to businesses and consumers across U.S. and international markets. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
AIGH Capital Dumps 1.1 Million MaxLinear (MXL) Shares ↗
This semiconductor company provides integrated RF and mixed-signal solutions for broadband, wireless, and industrial connectivity. 
Via The Motley Fool
A Whole Watchlist of “Coiled Springs” (Found With One Simple ChartMill Screen) ↗
Via Chartmill
News headline image
CS Diagnostics (OTCQB: CSDX) Advances Infection Control and Oncology Innovation Plus – IVP, SAFX, JTAI, OCG, BMXI Inside
Via AB Newswire
Topics Intellectual Property
News headline image
Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full–Year 2025 Results
From Castle Biosciences, Inc.
Via GlobeNewswire
News headline image
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Castle Biosciences, Inc.
Via GlobeNewswire
News headline image
Landmark Study Shows Combination of Castle Biosciences' DecisionDx®-UM and PRAME Outperforms Gene Mutation Analysis in Predicting Survival Outcomes in Uveal Melanoma
From Castle Biosciences, Inc.
Via GlobeNewswire
News headline image
Systematic Review and Meta-Analysis Confirms TissueCypher® Outperforms Traditional Pathology or Clinical Factors Alone to Identify Patients at Increased Risk of Developing Esophageal Cancer
Across multiple published studies, the test consistently identifies high-risk patients whose progression rates exceed guideline-based actionable thresholds for intensified care 
From Castle Biosciences, Inc.
Via GlobeNewswire
News headline image
Expert Melanoma Panel Recommends Castle Biosciences’ DecisionDx®-Melanoma as a Best-Practice Tool for Managing Patients with Melanoma
Expert panel offers data-driven guidance for integrating DecisionDx-Melanoma into clinical decision-making for patients with melanoma 
From Castle Biosciences, Inc.
Via GlobeNewswire
News headline image
Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fifth Consecutive Year
Castle also earns national recognition through three additional Top Workplaces Culture Excellence Awards — Employee Appreciation, Employee Well-Being and Professional Development 
From Castle Biosciences, Inc.
Via GlobeNewswire
News headline image
New Data Confirms Performance of DecisionDx®-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity
Second study to be presented at the 2nd European Congress on Dermato-Oncology demonstrates DecisionDx-Melanoma can identify patients with a negative sentinel lymph node who have a higher risk of poor... 
From Castle Biosciences, Inc.
Via GlobeNewswire
News headline image
Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference
From Castle Biosciences, Inc.
Via GlobeNewswire
News headline image
Why Castle Biosciences' Rally Might Just Be Getting Started ↗
Castle Biosciences' bullish structure is strengthening as momentum builds ahead of a possible breakout. 
Via Benzinga
News headline image
AMD To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
 
Via Benzinga
News headline image
Castle Biosciences Reports Third Quarter 2025 Results
From Castle Biosciences, Inc.
Via GlobeNewswire
News headline image
Castle Biosciences Launches AdvanceAD-Tx™ to Help Guide Systemic Treatment Decision Making in Patients with Moderate-to-Severe Atopic Dermatitis
Validation study data show AdvanceAD-Tx can identify patients with AD who have a ‘JAKi responder profile’ and a superior response to JAKi therapies compared to Th2-targeted therapies 
From Castle Biosciences, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.